Kore Private Wealth’s AtriCure ATRC Stock Holding History

Kore Private Wealth’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-29	Closed	-$1K	–	331
2020 Q2	$1K	Buy	+29	New	+$1.26K	﹤0.01%	1078

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kore Private Wealth's ATRC Position: Q3 2020 in Review

Kore Private Wealth sold out of AtriCure (ATRC) in Q3 2020, closing a stake of 29 shares — an estimated $1K sold.

Kore Private Wealth first reported a position in ATRC in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 183 funds tracked by Wall St. Rank hold ATRC as of Q3 2020.

Kore Private Wealth reported no remaining AtriCure position as of Q3 2020 after selling out during the quarter.
Kore Private Wealth sold 29 AtriCure shares in Q3 2020, an estimated $1K.
Kore Private Wealth first reported a position in AtriCure in Q2 2020 and held it in 1 quarter.
Kore Private Wealth's AtriCure position peaked at $1K in Q2 2020.
183 funds tracked by Wall St. Rank held AtriCure as of Q3 2020.

Based on Kore Private Wealth's 13F filing for Q3 2020, filed 13 Nov 2020.